Symptomatic Control of Neuroendocrine Tumors with Everolimus

被引：0
|
作者：
Bainbridge, H. [1 ]
Larbi, E. [2 ]
Middleton, G. [2 ]
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Royal Surrey Cty Hosp, Guildford, Surrey, England
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine; carcinoid; everolimus; symptom;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [31] ROLE OF RADIOMICS IN THE EVEROLIMUS RESPONSE PREDICTION OF METASTATIC GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS
    Polici, M.
    Magi, L.
    Zerunian, M.
    Rinzivillo, M.
    Caruso, D.
    Annibale, B.
    Laghi, A.
    Panzuto, F.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S186 - S186
  • [32] Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors
    Ge, Wenhao
    Zhou, Dongkai
    Zhu, Lijun
    Song, Wei
    Wang, Weilin
    JOURNAL OF CANCER, 2018, 9 (24): : 4783 - 4790
  • [33] Everolimus and transarterial embolization (TAE) for hepatic metastasis in neuroendocrine tumors (NET).
    Chauhan, Aman
    Magee, Gray
    Horn, Millicent
    Khouli, Riham
    Weiss, Heidi
    Krohmer, Steven J.
    Anthony, Lowell Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [34] Real-World Study on Everolimus in Advanced, Progressive Neuroendocrine Tumors
    Panzuto, F.
    Rinzivillo, M.
    Fazio, N.
    De Braud, F.
    Luppi, G.
    Degli Uberti, E.
    De Marinis, L.
    Tomassetti, P.
    Falconi, M.
    Delle Fave, G.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 277 - 277
  • [35] When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?
    Amoroso, Vito
    Fazio, Nicola
    Mosca, Alessandra
    Roca, Elisa
    Spada, Francesca
    Foroni, Chiara
    Agazzi, Giorgio Maria
    Berruti, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (13) : 1487 - +
  • [36] Everolimus and pancreatic neuroendocrine tumors ( PNETs): Activity, resistance and how to overcome it
    Capozzi, Monica
    Caterina, Ierano
    De Divitiis, Chiara
    von Arx, Claudia
    Maiolino, Piera
    Tatangelo, Fabiana
    Cavalcanti, Ernesta
    Di Girolamo, Elena
    Iaffaioli, Rosario Vincenzo
    Scala, Stefania
    Tafuto, Salvatore
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 21 : S89 - S94
  • [37] Long-Term Everolimus Treatment of Patients with Pancreatic Neuroendocrine Tumors
    Wolin, Edward M.
    CHEMOTHERAPY, 2014, 60 (03) : 143 - 150
  • [38] Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors
    Panzuto, Francesco
    Rinzivillo, Maria
    Fazio, Nicola
    de Braud, Filippo
    Luppi, Gabriele
    Zatelli, Maria Chiara
    Lugli, Francesca
    Tomassetti, Paola
    Riccardi, Ferdinando
    Nuzzo, Carmen
    Brizzi, Maria Pia
    Faggiano, Antongiulio
    Zaniboni, Alberto
    Nobili, Elisabetta
    Pastorelli, Davide
    Cascinu, Stefano
    Merlano, Marco
    Chiara, Silvana
    Antonuzzo, Lorenzo
    Funaioli, Chiara
    Spada, Francesca
    Pusceddu, Sara
    Fontana, Annalisa
    Ambrosio, Maria Rosaria
    Cassano, Alessandra
    Campana, Davide
    Carteni, Giacomo
    Appetecchia, Marialuisa
    Berruti, Alfredo
    Colao, Annamaria
    Falconi, Massimo
    Delle Fave, Gianfranco
    ONCOLOGIST, 2014, 19 (09): : 966 - 974
  • [39] Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors
    Liakakos, Theodore
    Roukos, Dimitrios H.
    FUTURE ONCOLOGY, 2011, 7 (09) : 1025 - 1029
  • [40] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
12345